Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Assets Average (2011 - 2026)

Palatin Technologies' (PTN) quarterly Assets Average came in at $15.6 million in Q1 2026, up 287.55% on a YoY basis from $4.0 million in Q1 2025, and up 17.37% quarter-over-quarter from $13.3 million in Q4 2025.

Analysis

Palatin Technologies (PTN) Assets Average (2011 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported Assets Average for 14 consecutive years, with $15.6 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Assets Average rose 287.55% year-over-year to $15.6 million; the trailing twelve-month figure through Mar 2026 stood at $15.6 million (up 287.55% YoY), and the FY2025 full-year result was $7.0 million, down 51.16% from the prior year.
  • Assets Average grew to $15.6 million in Q1 2026 per PTN's latest filing, from $13.3 million in the prior quarter.
  • Across five years, Assets Average topped out at $48.4 million in Q1 2022 and bottomed at $3.5 million in Q2 2025.
  • Historically, Assets Average has averaged $17.9 million across 5 years, with a median of $13.3 million in 2025.
  • The sharpest annual moves came in 2024 and 2026: Assets Average tumbled 68.85% in 2024, then soared 287.55% in 2026.
  • Over 5 years, Assets Average stood at $29.8 million in 2022, then plunged by 58.4% to $12.4 million in 2023, then sank by 68.85% to $3.9 million in 2024, then surged by 243.58% to $13.3 million in 2025, then rose by 17.37% to $15.6 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $15.6 million, $13.3 million, and $5.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 94.07 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 52.82 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 26.95 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 41.30 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 11.22 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 5.34 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 30.78 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 5.51 Bn
10 Palatin Technologies 46.98 Mn 46.98 Mn - 15.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 15.58 Mn
Dec 31, 2025 13.27 Mn
Sep 30, 2025 5.94 Mn
Jun 30, 2025 3.50 Mn
Mar 31, 2025 4.02 Mn
Dec 31, 2024 3.86 Mn
Sep 30, 2024 7.08 Mn
Jun 30, 2024 11.07 Mn
Mar 31, 2024 12.48 Mn
Dec 31, 2023 12.40 Mn
Sep 30, 2023 14.59 Mn
Jun 30, 2023 21.77 Mn
Mar 31, 2023 28.79 Mn
Dec 31, 2022 29.81 Mn
Sep 30, 2022 31.86 Mn
Jun 30, 2022 39.94 Mn
Mar 31, 2022 48.41 Mn
Dec 31, 2021 56.36 Mn
Sep 30, 2021 63.51 Mn
Jun 30, 2021 74.08 Mn